메뉴 건너뛰기




Volumn 39, Issue 3, 2014, Pages 312-321

Characteristics of functional bowel disorder patients: A cross-sectional survey using the Rome III criteria

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANXIETY; ARTICLE; BLOATING; BODY MASS; CANADA; CHRONIC IDIOPATHIC CONSTIPATION; COHORT ANALYSIS; COLITIS; COLONOSCOPY; COMPARATIVE STUDY; CONSTIPATION; CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME; CONTROLLED STUDY; CROHN COLITIS; CROHN DISEASE; CROSS-SECTIONAL STUDY; DEPRESSION; DIARRHEA; DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME; FEMALE; FUNCTIONAL BOWEL DISORDER; FUNCTIONAL DIARRHEA; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRRITABLE BOWEL SYNDROME UNSUBTYPED; IRRITABLE COLON; LOOSE FECES; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MIXED STOOL PATTERN IRRITABLE BOWEL SYNDROME; OUTPATIENT; PAINFUL DEFECATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROCTITIS; PSYCHOSOMATICS; QUESTIONNAIRE; RECTUM CARCINOMA; SECONDARY HEALTH CARE; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SYMPTOMATOLOGY; ULCERATIVE COLITIS; VERY ELDERLY;

EID: 84891877164     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12573     Document Type: Article
Times cited : (89)

References (41)
  • 2
    • 84862651150 scopus 로고    scopus 로고
    • Global prevalence of, and risk factors for, irritable bowel syndrome: A meta-analysis
    • Lovell RM, Ford AC,. Global prevalence of, and risk factors for, irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712-21.
    • (2012) Clin Gastroenterol Hepatol , vol.10 , pp. 712-721
    • Lovell, R.M.1    Ford, A.C.2
  • 3
    • 80052461147 scopus 로고    scopus 로고
    • Prevalence of, and risk factors for, chronic idiopathic constipation in the community: Systematic review and meta-analysis
    • Suares NC, Ford AC,. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol 2011; 106: 1582-91.
    • (2011) Am J Gastroenterol , vol.106 , pp. 1582-1591
    • Suares, N.C.1    Ford, A.C.2
  • 4
    • 42349110328 scopus 로고    scopus 로고
    • Prevalence and consultation behavior of self-reported rectal bleeding by face-to-face interview in an Asian community
    • Basaranoglu M, Celebi S, Ataseven H, Rahman S, Deveci SE, Acik Y,. Prevalence and consultation behavior of self-reported rectal bleeding by face-to-face interview in an Asian community. Digestion 2008; 77: 10-5.
    • (2008) Digestion , vol.77 , pp. 10-15
    • Basaranoglu, M.1    Celebi, S.2    Ataseven, H.3    Rahman, S.4    Deveci, S.E.5    Acik, Y.6
  • 5
    • 0034200752 scopus 로고    scopus 로고
    • Normal bowel habits and prevalence of functional bowel disorders in Singaporean adults - Findings from a community based study in Bishan
    • Chen LY, Ho KY, Phua KH,. Normal bowel habits and prevalence of functional bowel disorders in Singaporean adults-findings from a community based study in Bishan. Singapore Med J 2000; 41: 255-8.
    • (2000) Singapore Med J , vol.41 , pp. 255-258
    • Chen, L.Y.1    Ho, K.Y.2    Phua, K.H.3
  • 6
    • 0027185528 scopus 로고
    • U.S. Householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact
    • Drossman DA, Li Z, Andruzzi E, et al,. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-80.
    • (1993) Dig Dis Sci , vol.38 , pp. 1569-1580
    • Drossman, D.A.1    Li, Z.2    Andruzzi, E.3
  • 7
    • 0344097310 scopus 로고    scopus 로고
    • Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms
    • Ho KY, Kang JY, Seow A,. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol 1998; 93: 1816-22.
    • (1998) Am J Gastroenterol , vol.93 , pp. 1816-1822
    • Ho, K.Y.1    Kang, J.Y.2    Seow, A.3
  • 8
    • 0036147287 scopus 로고    scopus 로고
    • Functional gastrointestinal disorders in Canada: First population-based survey using Rome II criteria with suggestions for improving the questionnaire
    • Thompson WG, Irvine EJ, Pare P, Ferrazzi S, Rance L,. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002; 47: 225-35.
    • (2002) Dig Dis Sci , vol.47 , pp. 225-235
    • Thompson, W.G.1    Irvine, E.J.2    Pare, P.3    Ferrazzi, S.4    Rance, L.5
  • 10
    • 84856580322 scopus 로고    scopus 로고
    • Natural history of functional gastrointestinal disorders: Comparison of two longitudinal population-based studies
    • Olafsdottir LB, Gudjonsson H, Jonsdottir HH, Bjornsson E, Thjodleifsson B,. Natural history of functional gastrointestinal disorders: comparison of two longitudinal population-based studies. Dig Liver Dis 2012; 44: 211-7.
    • (2012) Dig Liver Dis , vol.44 , pp. 211-217
    • Olafsdottir, L.B.1    Gudjonsson, H.2    Jonsdottir, H.H.3    Bjornsson, E.4    Thjodleifsson, B.5
  • 11
    • 77957826668 scopus 로고    scopus 로고
    • Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome
    • Wong RK, Palsson O, Turner MJ, et al,. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. Am J Gastroenterol 2010; 105: 2228-34.
    • (2010) Am J Gastroenterol , vol.105 , pp. 2228-2234
    • Wong, R.K.1    Palsson, O.2    Turner, M.J.3
  • 12
    • 84888299584 scopus 로고    scopus 로고
    • Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care
    • Ford AC, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P,. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology 2013; 145: 1262-70.
    • (2013) Gastroenterology , vol.145 , pp. 1262-1270
    • Ford, A.C.1    Bercik, P.2    Morgan, D.G.3    Bolino, C.4    Pintos-Sanchez, M.I.5    Moayyedi, P.6
  • 13
    • 35348833036 scopus 로고    scopus 로고
    • Development and validation of the Rome III diagnostic questionnaire
    • the Validation Working Team Committee in association with the Rome Questionnaire Committee. Drossman D.A. ed. 3rd ed. Virginia: Degnon Associates Inc
    • Whitehead WE, and the Validation Working Team Committee in association with the Rome Questionnaire Committee. Development and validation of the Rome III diagnostic questionnaire. In:, Drossman DA, ed. Rome III: the functional gastrointestinal disorders, 3rd ed. Virginia: Degnon Associates Inc, 2006; 835-53.
    • (2006) Rome III: The Functional Gastrointestinal Disorders , pp. 835-853
    • Whitehead, W.E.1
  • 14
    • 0020527558 scopus 로고
    • The hospital anxiety and depression scale
    • Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
    • (1983) Acta Psychiatr Scand , vol.67 , pp. 361-370
    • Zigmond, A.S.1    Snaith, R.P.2
  • 15
    • 0036208937 scopus 로고    scopus 로고
    • The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms
    • Kroenke K, Spitzer RL, Williams JBW,. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64: 258-66.
    • (2002) Psychosom Med , vol.64 , pp. 258-266
    • Kroenke, K.1    Spitzer, R.L.2    Williams, J.B.W.3
  • 17
    • 84860649408 scopus 로고    scopus 로고
    • The brain-gut pathway in functional gastrointestinal disorders is bidirectional: A 12-year prospective population-based study
    • Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ,. The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut 2012; 61: 1284-90.
    • (2012) Gut , vol.61 , pp. 1284-1290
    • Koloski, N.A.1    Jones, M.2    Kalantar, J.3    Weltman, M.4    Zaguirre, J.5    Talley, N.J.6
  • 18
    • 84881311518 scopus 로고    scopus 로고
    • Abdominal pain is associated with anxiety and depression scores in a sample of the general adult population with no signs of organic gastrointestinal disease
    • Walter SA, Jones MP, Talley NJ, et al,. Abdominal pain is associated with anxiety and depression scores in a sample of the general adult population with no signs of organic gastrointestinal disease. Neurogastroenterol Motil 2013; 25: 741-e576.
    • (2013) Neurogastroenterol Motil , vol.25
    • Walter, S.A.1    Jones, M.P.2    Talley, N.J.3
  • 19
    • 84884418594 scopus 로고    scopus 로고
    • Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin
    • Shekhar C, Monaghan PJ, Morris J, et al,. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Gastroenterology 2013; 145: 749-57.
    • (2013) Gastroenterology , vol.145 , pp. 749-757
    • Shekhar, C.1    Monaghan, P.J.2    Morris, J.3
  • 20
    • 84869491248 scopus 로고    scopus 로고
    • Linaclotide for irritable bowel syndrome with constipation: A 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety
    • Chey WD, Lembo AJ, Lavins BJ, et al,. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am J Gastroenterol 2012; 107: 1702-12.
    • (2012) Am J Gastroenterol , vol.107 , pp. 1702-1712
    • Chey, W.D.1    Lembo, A.J.2    Lavins, B.J.3
  • 21
    • 58149103805 scopus 로고    scopus 로고
    • Clinical trial: Lubiprostone in patients with constipation-associated irritable bowel syndrome - Results of two randomized, placebo-controlled studies
    • Drossman DA, Chey WD, Johanson JF, et al,. Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome-results of two randomized, placebo-controlled studies. Aliment Pharmacol Ther 2009; 29: 329-41.
    • (2009) Aliment Pharmacol Ther , vol.29 , pp. 329-341
    • Drossman, D.A.1    Chey, W.D.2    Johanson, J.F.3
  • 23
    • 78651086264 scopus 로고    scopus 로고
    • Effect of laxatives and pharmacological therapies in chronic idipathic constipation: Systematic review and meta-analysis
    • Ford AC, Suares NC,. Effect of laxatives and pharmacological therapies in chronic idipathic constipation: systematic review and meta-analysis. Gut 2011; 60: 209-18.
    • (2011) Gut , vol.60 , pp. 209-218
    • Ford, A.C.1    Suares, N.C.2
  • 24
    • 77249122338 scopus 로고    scopus 로고
    • Efficacy of linaclotide for patients with chronic constipation
    • Lembo AJ, Kurtz CB, MacDougall JE, et al,. Efficacy of linaclotide for patients with chronic constipation. Gastroenterology 2010; 138: 886-95.
    • (2010) Gastroenterology , vol.138 , pp. 886-895
    • Lembo, A.J.1    Kurtz, C.B.2    Macdougall, J.E.3
  • 25
    • 84869493876 scopus 로고    scopus 로고
    • 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation
    • Rao S, Lembo AJ, Shiff SJ, et al,. 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation. Am J Gastroenterol 2012; 107: 1714-24.
    • (2012) Am J Gastroenterol , vol.107 , pp. 1714-1724
    • Rao, S.1    Lembo, A.J.2    Shiff, S.J.3
  • 27
    • 84883744403 scopus 로고    scopus 로고
    • Randomized clinical trial: Macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome
    • Chapman RW, Stanghellini V, Geraint M, Halphen M,. Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome. Am J Gastroenterol 2013; 108: 1508-15.
    • (2013) Am J Gastroenterol , vol.108 , pp. 1508-1515
    • Chapman, R.W.1    Stanghellini, V.2    Geraint, M.3    Halphen, M.4
  • 28
    • 10744225624 scopus 로고    scopus 로고
    • Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome
    • Barbara G, Stanghellini V, De Giorgio R, et al,. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693-702.
    • (2004) Gastroenterology , vol.126 , pp. 693-702
    • Barbara, G.1    Stanghellini, V.2    De Giorgio, R.3
  • 29
    • 33846193703 scopus 로고    scopus 로고
    • Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome
    • Barbara G, Wang B, Stanghellini V, et al,. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007; 132: 26-37.
    • (2007) Gastroenterology , vol.132 , pp. 26-37
    • Barbara, G.1    Wang, B.2    Stanghellini, V.3
  • 31
    • 69949136438 scopus 로고    scopus 로고
    • Systematic review: The prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome
    • Wedlake L, A'Hern R, Russell D, Thomas K, Walters JR, Andreyev HJ,. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009; 30: 707-17.
    • (2009) Aliment Pharmacol Ther , vol.30 , pp. 707-717
    • Wedlake, L.1    A'Hern, R.2    Russell, D.3    Thomas, K.4    Walters, J.R.5    Andreyev, H.J.6
  • 32
    • 84884355706 scopus 로고    scopus 로고
    • Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome
    • Shin A, Camilleri M, Vijayvargiya P, et al,. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013; 11: 1270-5.
    • (2013) Clin Gastroenterol Hepatol , vol.11 , pp. 1270-1275
    • Shin, A.1    Camilleri, M.2    Vijayvargiya, P.3
  • 33
    • 84865313567 scopus 로고    scopus 로고
    • Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea
    • Wong BS, Camilleri M, Carlson P, et al,. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol 2012; 10: 1009-15.
    • (2012) Clin Gastroenterol Hepatol , vol.10 , pp. 1009-1015
    • Wong, B.S.1    Camilleri, M.2    Carlson, P.3
  • 34
    • 79958173090 scopus 로고    scopus 로고
    • Randomised clinical trial: The ileal bile acid transporter inhibitor A3309 vs. Placebo in patients with chronic idiopathic constipation-A double-blind study
    • Simren M, Bajor A, Gillberg PG, Rudling M, Abrahamsson H,. Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation-a double-blind study. Aliment Pharmacol Ther 2011; 34: 41-50.
    • (2011) Aliment Pharmacol Ther , vol.34 , pp. 41-50
    • Simren, M.1    Bajor, A.2    Gillberg, P.G.3    Rudling, M.4    Abrahamsson, H.5
  • 35
    • 80053912847 scopus 로고    scopus 로고
    • A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation
    • Chey WD, Camilleri M, Chang L, Rikner L, Graffner H,. A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am J Gastroenterol 2011; 106: 1803-12.
    • (2011) Am J Gastroenterol , vol.106 , pp. 1803-1812
    • Chey, W.D.1    Camilleri, M.2    Chang, L.3    Rikner, L.4    Graffner, H.5
  • 36
    • 84877911333 scopus 로고    scopus 로고
    • Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome
    • Camilleri M,. Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome. Expert Opin Pharmacother 2013; 14: 1151-60.
    • (2013) Expert Opin Pharmacother , vol.14 , pp. 1151-1160
    • Camilleri, M.1
  • 37
    • 2342524628 scopus 로고    scopus 로고
    • New approaches to enhance the accuracy of the diagnosis of reflux disease
    • Moayyedi P, Duffy J, Delaney B,. New approaches to enhance the accuracy of the diagnosis of reflux disease. Gut 2004; 53 (Suppl. 4): iv55-7.
    • (2004) Gut , vol.53 , Issue.SUPPL. 4
    • Moayyedi, P.1    Duffy, J.2    Delaney, B.3
  • 39
    • 84856720903 scopus 로고    scopus 로고
    • Serum and colonic mucosal immune markers in irritable bowel syndrome
    • Chang L, Adeyemo M, Karagiannides I, et al,. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol 2012; 107: 262-72.
    • (2012) Am J Gastroenterol , vol.107 , pp. 262-272
    • Chang, L.1    Adeyemo, M.2    Karagiannides, I.3
  • 40
    • 84856758488 scopus 로고    scopus 로고
    • Abnormal immune regulation and low-grade inflammation in IBS: Does one size fit all?
    • Schmulson M, Chey WD,. Abnormal immune regulation and low-grade inflammation in IBS: does one size fit all? Am J Gastroenterol 2012; 107: 273-5.
    • (2012) Am J Gastroenterol , vol.107 , pp. 273-275
    • Schmulson, M.1    Chey, W.D.2
  • 41
    • 84885627125 scopus 로고    scopus 로고
    • A multidimensional model of psychobiological interactions in functional dyspepsia: A structural equation modelling approach
    • Jones MP, Coppens E, Vos R, et al,. A multidimensional model of psychobiological interactions in functional dyspepsia: a structural equation modelling approach. Gut 2013; 62: 1573-80.
    • (2013) Gut , vol.62 , pp. 1573-1580
    • Jones, M.P.1    Coppens, E.2    Vos, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.